Your browser doesn't support javascript.
loading
Cellular and humoral functional responses after BNT162b2 mRNA vaccination differ longitudinally between naive and subjects recovered from COVID-19.
Lozano-Rodríguez, Roberto; Valentín-Quiroga, Jaime; Avendaño-Ortiz, José; Martín-Quirós, Alejandro; Pascual-Iglesias, Alejandro; Terrón-Arcos, Verónica; Montalbán-Hernández, Karla; Casalvilla-Dueñas, José Carlos; Bergón-Gutiérrez, Marta; Alcamí, José; García-Pérez, Javier; Cascajero, Almudena; García-Garrido, Miguel Ángel; Balzo-Castillo, Álvaro Del; Peinado, María; Gómez, Laura; Llorente-Fernández, Irene; Martín-Miguel, Gema; Herrero-Benito, Carmen; Benito, José Miguel; Rallón, Norma; Vela-Olmo, Carmen; López-Morejón, Lissette; Cubillos-Zapata, Carolina; Aguirre, Luis A; Fresno, Carlos Del; López-Collazo, Eduardo.
Afiliación
  • Lozano-Rodríguez R; The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain; Tumor Immunology Laboratory, IdiPAZ, La Paz University Hospital, Madrid, Spain.
  • Valentín-Quiroga J; The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain; Tumor Immunology Laboratory, IdiPAZ, La Paz University Hospital, Madrid, Spain.
  • Avendaño-Ortiz J; The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain; Tumor Immunology Laboratory, IdiPAZ, La Paz University Hospital, Madrid, Spain.
  • Martín-Quirós A; Emergency Department and Emergent Pathology Research Group, IdiPAZ La Paz University Hospital, Madrid, Spain.
  • Pascual-Iglesias A; The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain; Tumor Immunology Laboratory, IdiPAZ, La Paz University Hospital, Madrid, Spain.
  • Terrón-Arcos V; The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain; Tumor Immunology Laboratory, IdiPAZ, La Paz University Hospital, Madrid, Spain.
  • Montalbán-Hernández K; The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain; Tumor Immunology Laboratory, IdiPAZ, La Paz University Hospital, Madrid, Spain.
  • Casalvilla-Dueñas JC; The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain; Tumor Immunology Laboratory, IdiPAZ, La Paz University Hospital, Madrid, Spain.
  • Bergón-Gutiérrez M; The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain; Tumor Immunology Laboratory, IdiPAZ, La Paz University Hospital, Madrid, Spain.
  • Alcamí J; AIDS Immunopathogenesis Unit, National Microbiology Centre, Instituto de Salud Carlos III, Madrid, Spain.
  • García-Pérez J; AIDS Immunopathogenesis Unit, National Microbiology Centre, Instituto de Salud Carlos III, Madrid, Spain.
  • Cascajero A; AIDS Immunopathogenesis Unit, National Microbiology Centre, Instituto de Salud Carlos III, Madrid, Spain.
  • García-Garrido MÁ; Emergency Department and Emergent Pathology Research Group, IdiPAZ La Paz University Hospital, Madrid, Spain.
  • Balzo-Castillo ÁD; The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain; Emergency Department and Emergent Pathology Research Group, IdiPAZ La Paz University Hospital, Madrid, Spain.
  • Peinado M; Emergency Department and Emergent Pathology Research Group, IdiPAZ La Paz University Hospital, Madrid, Spain.
  • Gómez L; Emergency Department and Emergent Pathology Research Group, IdiPAZ La Paz University Hospital, Madrid, Spain.
  • Llorente-Fernández I; Intensive Care Unit, Infanta Cristina University Hospital, Parla, Madrid, Spain.
  • Martín-Miguel G; Pediatric Intensive Care Unit, 12 de Octubre University Hospital, Madrid, Spain.
  • Herrero-Benito C; Emergency Department and Emergent Pathology Research Group, IdiPAZ La Paz University Hospital, Madrid, Spain.
  • Benito JM; HIV and Viral Hepatitis Research Laboratory, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain; Hospital Universitario Rey Juan Carlos, Móstoles, Spain.
  • Rallón N; HIV and Viral Hepatitis Research Laboratory, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain; Hospital Universitario Rey Juan Carlos, Móstoles, Spain.
  • Vela-Olmo C; Eurofins-Ingenasa, Madrid, Spain.
  • López-Morejón L; Eurofins-Ingenasa, Madrid, Spain.
  • Cubillos-Zapata C; The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain; Tumor Immunology Laboratory, IdiPAZ, La Paz University Hospital, Madrid, Spain; CIBER of Respiratory Diseases (CIBERES), Madrid, Spain.
  • Aguirre LA; The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain; Tumor Immunology Laboratory, IdiPAZ, La Paz University Hospital, Madrid, Spain.
  • Fresno CD; The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain; Tumor Immunology Laboratory, IdiPAZ, La Paz University Hospital, Madrid, Spain. Electronic address: carlos.delfresno.sanchez@idipaz.es.
  • López-Collazo E; The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain; Tumor Immunology Laboratory, IdiPAZ, La Paz University Hospital, Madrid, Spain; CIBER of Respiratory Diseases (CIBERES), Madrid, Spain. Electronic address: elopezc@salud.madrid.org.
Cell Rep ; 38(2): 110235, 2022 01 11.
Article en En | MEDLINE | ID: mdl-34986327
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas Sintéticas / Inmunidad Humoral / Vacunas contra la COVID-19 / COVID-19 / Vacunas de ARNm / Vacuna BNT162 / Inmunidad Celular Límite: Animals / Humans Idioma: En Revista: Cell Rep Año: 2022 Tipo del documento: Article País de afiliación: España Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas Sintéticas / Inmunidad Humoral / Vacunas contra la COVID-19 / COVID-19 / Vacunas de ARNm / Vacuna BNT162 / Inmunidad Celular Límite: Animals / Humans Idioma: En Revista: Cell Rep Año: 2022 Tipo del documento: Article País de afiliación: España Pais de publicación: Estados Unidos